Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Progesterone 💬
(Progesterone (JP18/USP/INN))		[1] Progesterone (Reddy-progesterone)[1] Progesterone[1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[2] 76, 299 💬
2 Estradiol 💬[1] Estradiol (Estradiol and Progesterone)[1] Estradiol[2] ESR1,
ESR2 💬 		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[7] 13, 46, 49, 65, 76, 226, 299 💬
3 Medroxyprogesterone acetate 💬[1] Medroxyprogesterone acetate (6α-Methyl-17-acetoxy progesterone)[1] Medroxyprogesterone[1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 49 💬
4 Megestrol acetate 💬[1] Megestrol acetate (6-Methyl-17α-hydroxy-delta-progesterone acetate)[1] Megestrol acetate[1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 76 💬
5 Dydrogesterone 💬[1] Dydrogesterone (6-Dehydro-retro-progesterone)[1] DYDROGESTERONE[1] PGR 💬 [5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 13 💬